Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose Monitoring
| Status: | Completed |
|---|---|
| Conditions: | Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - 75 |
| Updated: | 4/21/2016 |
| Start Date: | February 2010 |
| End Date: | January 2012 |
Optimization of SMBG Employing Modal Day Analysis: Examining Clinical Decision-making Processes Using Blinded FreeStyle Navigator Continuous Glucose Monitoring System (CGM)
The purpose of this study is to evaluate the effectiveness of Self Monitoring of Blood
Glucose (SMBG) for clinical decisions related to the management of type 2 diabetes and to
determine the benefit of using Continuous Glucose Monitoring (CGM) for clinical diabetes
management.
Glucose (SMBG) for clinical decisions related to the management of type 2 diabetes and to
determine the benefit of using Continuous Glucose Monitoring (CGM) for clinical diabetes
management.
Inclusion Criteria:
- Male or female subjects ≥18 and ≤75 years of age
- Clinical diagnosis of diabetes
- Diabetes duration ≥ 1 year
- HbA1c ≥7.2%
- Diabetes can be treated with any therapy including medical nutrition therapy alone
and any pharmaceutical therapy
Exclusion Criteria:
- Taken prednisone or cortisone medications in the previous 30 days
- Currently pregnant or planning pregnancy during the study period
- Presence of any severe medical or psychological condition or chronic
conditions/infections that in the opinion of the Investigator would compromise the
subject's safety or successful participation in the study
- Unable to follow the study protocol
- Unable to speak, read and write in English
We found this trial at
1
site
Click here to add this to my saved trials
